Pardes Biosciences Inc Ordinary Shares PRDS 深 沪
等待开盘 11-09 09:30:00 美东时间
2.16
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.16
- 总市值 13.39万
- 52周最高 3.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.75
- 委 比 0.00%
- 总股本 6.20万
- 历史最高 17.76
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.75
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Entera Bio Ltd. announced the appointment of Laura Hamill to its Board of Directors, effective December 1, 2026. With over 35 years of experience in global commercial leadership, Hamill joins Entera as it advances its late-stage clinical trials and prepares for the commercialization of EB613, an oral therapy for osteoporosis. Hamill previously served at Gilead Sciences and Amgen, leading multi-billion dollar franchises. Her expertise is expected ...
10-06 12:00
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm
NEW YORK, Aug. 3, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims con...
2023-08-04 03:15
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Upgrades For Carnival Corp (NYSE:CCL), Argus Research upgraded the previous rat...
2023-07-18 23:00
Pardes Biosciences Analyst Ratings
What is the target price for Pardes Biosciences (PRDS)? The latest price tar...
2023-07-18 17:22
JMP Securities Downgrades Pardes Biosciences to Market Perform
JMP Securities analyst Roy Buchanan downgrades Pardes Biosciences (NASDAQ:PRDS) from Market Outperform to Market Perform.
2023-07-18 17:22
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL
NEW YORK, July 17, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-07-18 05:28
Why Pardes Biosciences Shares Are Rising Monday
Pardes Biosciences Inc (NASDAQ: PRDS) shares are trading higher Monday after MediPacific agreed to acquire the company.
2023-07-17 21:25
Recap: Pardes Biosciences Q1 Earnings
Pardes Biosciences (NASDAQ:PRDS) reported its Q1 earnings results on Friday, Ma...
2023-05-06 04:05
Pardes Biosciences Q1 EPS $(0.30) Beats $(0.41) Estimate
Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.41) by 26.83 percent. This is a 21.05 percent increase over losses of $(0.38) per share
2023-05-06 04:01
Comparing Pardes Biosciences (PRDS) and Its Competitors
Pardes Biosciences (NASDAQ:PRDS – Get Rating) is one of 993 public companies in...
2023-04-22 17:23
